Skip to main content

Focus Areas

Finding innovative solutions for unmet medical needs is at the heart of what we do. Our ideas and research help save lives.

  • Haemophilia

    Pharma

    Haemophilia is a severe inherited bleeding disorder in which the blood does not clot properly.

  • Idiopathic Pulmonary Fibrosis

    Pharma

    The diagnosis of idiopathic pulmonary fibrosis (IPF) is frightening, unsettling and raises many questions.

  • Lymphoma

    Pharma

    For more than 20 years, we have been committed to helping people with lymphoma, for whom there are currently only limited treatment options.

  • Two man having conversation with each other.

    Multiple sclerosis

    Pharma

    Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is classified as an autoimmune disorder.

  • Oncology

    Solutions

    Oncology is the science of the origin and development of cancer and deals with the prevention, diagnosis, treatment and aftercare of malignant tumors.

  • Neuromyelitis optica spectrum disorder (NMOSD)

    Pharma

    Through innovation and partnerships, we offer people with NMOSD treatment options that help maintain their independence as much as possible.

  • Viral Hepatitis

    Pharma

    Hepatitis B and C are viral infections that can lead to severe liver damage if left undetected.

  • An elderly woman engages with a doctor.

    Neurology

    Solutions

    There are hundreds of diseases of the nervous system that affect millions of people worldwide.

  • A young woman with a braid smiles gently while sitting in a wheelchair outdoors, surrounded by hanging green leaves with soft sunlight filtering through in a peaceful garden setting.

    Spinal Muscular Atrophy

    Solutions

    Spinal Muscular Atrophy (SMA) is a rare genetic disease. Due to a genetic defect, the SMN protein is not produced in sufficient quantities.

Discover more

From molecule to medicine

Pharma Switzerland

Roche utilises cutting-edge technologies to create numerous new chemical compounds in the laboratory by combining known elements.